Abstract
The consideration of race/ethnicity differences in the prevalence, management, and outcome of atherosclerotic cardiovascular disease (ASCVD) is essential in evaluating related disparities. While racial/ethnic categories are imperfect for determining perceived genetic differences, race/ethnicity descriptions can highlight social similarities and perceived physiological differences, often revealing disparate treatment and outcomes. As the reasons for racial/ethnic disparities in cardiovascular disease are challenging to understand and multilevel in complexity, this chapter will review racial/ethnic differences in the epidemiology, health behaviors, risk factors, and treatment of cardiovascular disease in the US populations. As much of the attributable risk of worsening disparate racial/ethnic outcomes in ASCVD is secondary to risk factor control, there are ample opportunities to improve racial/ethnic disparities through primary prevention and promotion of healthy lifestyle behaviors. Detailing these behaviors is essential in investigating ASCVD disparities among racial/ethnic groups. While public health campaigns have successfully decreased the cardiovascular disease burden implicated by adverse risk behaviors, personal patterns of lifestyle continue to be substantial factors affecting the degree of ASCVD disparities among all racial/ethnic groups. Lessening barriers to healthcare access, addressing social determinants of health, and overcoming differential medical treatments among minority racial/ethnic populations will further the ultimate mission of achieving health equity in all populations.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
About Race United States Census Bureau. [Cited 2020 January 14]. Available from: https://www.census.gov/topics/population/race/about.html
Mensah GA, et al. Emerging concepts in precision medicine and cardiovascular diseases in racial and ethnic minority populations. Circ Res. 2019;125(1):7–13.
Office of Management and Budget (OMB) Directive No. 15 Race and ethnic standards for federal statistics and administrative reporting (as adopted on May 12, 1977) [Cited 2020 January 14]. Available from: https://wonder.cdc.gov/wonder/help/populations/bridged-race/directive15.html
Nelson HD, Cantor A, Wagner J, et al. Achieving health equity in preventive services [Internet]. Rockville: Agency for Healthcare Research and Quality (US); 2019.
Kochanek MA, Kenneth D, et al. Deaths: final data for 2017. Natl Vital Stat Rep. 2019;68(9):77.
Racial, Ethnic, and Minority Groups. [Cited 2020 January 14]. Available from: https://opentextbc.ca/introsociology2eopenstax/chapter/racial-ethnic-and-minority-groups/
Lawton BL, Foeman A, Surdel N. Bridging discussions of human history: ancestry DNA and new roles for Africana studies. Genealogy. 2018 [Cited 2020 February 7]. Available from: https://www.researchgate.net/publication/324809019_Bridging_Discussions_of_Human_History_Ancestry_DNA_and_New_Roles_for_Africana_Studies/fulltext/5a668cd1aca2720ba6af52ae/324809019_Bridging_Discussions_of_Human_History_Ancestry_DNA_and_New_Roles_for_Africana_Studies.pdf?origin=publication_detail
Kim Parker JMH, Morin R, Lopez MH. Multiracial in America chapter 7: the many dimensions of Hispanic racial identity. [Cited 2020 January 26]. Available from: https://www.pewsocialtrends.org/2015/06/11/chapter-7-the-many-dimensions-of-hispanic-racial-identity/
Magnan S. Social determinants of health 101 for health care: five plus five. 2017. Available from: https://nam.edu/social-determinants-of-health-101-for-health-care-five-plus-five/
Carnethon MR, et al. Cardiovascular health in African Americans: a scientific statement from the American Heart Association. Circulation. 2017;136(21):e393–423.
Virani SS, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020:Cir0000000000000757.
Benjamin EJ, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–e528.
Kershaw KN, et al. Association of changes in neighborhood-level racial residential segregation with changes in blood pressure among black adults: the CARDIA study. JAMA Intern Med. 2017;177(7):996–1002.
Arnett DK, et al. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2019;74(10):1376–414.
Tibuakuu M, et al. Air pollution and cardiovascular disease: a focus on vulnerable populations worldwide. Curr Epidemiol Rep. 2018;5(4):370–8.
Harlow AF, Stokes A, Brooks DR. Socioeconomic and racial/ethnic differences in e-cigarette uptake among cigarette smokers: longitudinal analysis of the population assessment of tobacco and health (PATH) study. Nicotine Tob Res. 2019;21(10):1385–93.
Ma JZ, et al. Perceived health risks of electronic nicotine delivery systems (ENDS) users: the role of cigarette smoking status. Addict Behav. 2019;91:156–63.
Vu TT, et al. Socioeconomic and demographic status and perceived health risks of e-cigarette product contents among youth: results from a national survey. Health Promot Pract. 2020;21(1_Suppl):148s–56s.
Adakai M, et al. Health disparities among American Indians/Alaska Natives – Arizona, 2017. MMWR Morb Mortal Wkly Rep. 2018;67(47):1314–8.
Fang J, et al. Cardiovascular health among non-Hispanic Asian Americans: NHANES, 2011–2016. J Am Heart Assoc. 2019;8(13):e011324.
Chen L, et al. Sodium reduction, metabolomic profiling, and cardiovascular disease risk in untreated black hypertensives. Hypertension. 2019;74(1):194–200.
Han L, et al. National trends in American Heart Association revised life’s simple 7 metrics associated with risk of mortality among US adults. JAMA Netw Open. 2019;2(10):e1913131.
Safford MM, et al. Association of race and sex with risk of incident acute coronary heart disease events. JAMA. 2012;308(17):1768–74.
Whelton PK, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APHA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2018;138(17):e426–83.
Hu EA, et al. Adherence to the healthy eating index-2015 and other dietary patterns may reduce risk of cardiovascular disease, cardiovascular mortality, and all-cause mortality. J Nutr. 2020;150(2):312–21.
Chen Y, et al. Association of cardiovascular disease with premature mortality in the United States. JAMA Cardiol. 2019;4(12):1230–8.
Chen L, et al. Race, gender, family structure, socioeconomic status, dietary patterns, and cardiovascular health in adolescents. Curr Dev Nutr. 2019;3(11):nzz117.
Ferdinand KC, et al. Improving medication adherence in cardiometabolic disease: practical and regulatory implications. J Am Coll Cardiol. 2017;69(4):437–51.
Victor RG, et al. Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med. 2011;171(4):342–50.
Victor RG, et al. A cluster-randomized trial of blood-pressure reduction in black barbershops. N Engl J Med. 2018;378(14):1291–301.
Balfour PC Jr, Rodriguez CJ, Ferdinand KC. The role of hypertension in race-ethnic disparities in cardiovascular disease. Curr Cardiovasc Risk Rep. 2015;9(4):18.
Shrout T, Rudy DW, Piascik MT. Hypertension update, JNC8 and beyond. Curr Opin Pharmacol. 2017;33:41–6.
Howard G, et al. Association of clinical and social factors with excess hypertension risk in black compared with white US adults. JAMA. 2018;320(13):1338–48.
Al Kibria GM. Racial/ethnic disparities in prevalence, treatment, and control of hypertension among US adults following application of the 2017 American College of Cardiology/American Heart Association guideline. Prev Med Rep. 2019;14:100850.
Estimated hypertension prevalence, treatment, and control among U.S. adults tables. 2019 [Cited 2020 January 31]. Available from: https://millionhearts.hhs.gov/data-reports/hypertension-prevalence-tables.html#Table1
Forrester SJ, Dolmatova EV, Griendling KK. An acceleration in hypertension-related mortality for middle-aged and older Americans, 1999–2016: an observational study. PLoS One. 2020;15(1):e0225207.
Ferdinand KC. Novel interventions in addressing racial disparities in blood pressure control. Circulation. 2018;138(4):339–41.
Cheng YJ, et al. Trends and disparities in cardiovascular mortality among U.S. adults with and without self-reported diabetes, 1988–2015. Diabetes Care. 2018;41(11):2306–15.
American Diabetes Association Standards of medical care in diabetes—2020. J Clin Appl Res Educ Diabetes Care. 2020;43:1–224.
Grundy SM, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APHA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019;139(25):e1046–81.
Jacobson TA, et al. National lipid association recommendations for patient-centered management of dyslipidemia: part 2. J Clin Lipidol. 2015;9(6 Suppl):S1–122.e1.
Ahmad ZS, et al. US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry. J Clin Lipidol. 2016;10(5):1223–9.
Amrock SM, et al. Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH patient registry. Atherosclerosis. 2017;267:19–26.
deGoma EM, et al. Treatment gaps in adults with heterozygous familial hypercholesterolemia in the United States: data from the CASCADE-FH Registry. Circ Cardiovasc Genet. 2016;9(3):240–9.
Duell PB, et al. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: the CASCADE FH registry. Atherosclerosis. 2019;289:85–93.
Grundy SM, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APHA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2019;73(24):3168–209.
Dorsch MP, et al. Effects of race on statin prescribing for primary prevention with high atherosclerotic cardiovascular disease risk in a large healthcare system. J Am Heart Assoc. 2019;8(22):e014709.
Aminian A, et al. Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity. JAMA. 2019;322(13):1271–82.
Bell RA, et al. Comparison of measures of adiposity and cardiovascular disease risk factors among African American Adults: the Jackson Heart Study. J Racial Ethn Health Disparities. 2018;5(6):1230–7.
Ferdinand KC, et al. Cardiorenal metabolic syndrome and cardiometabolic risks in minority populations. Cardiorenal Med. 2014;4(1):1–11.
Ferdinand KC. Coronary artery disease in minority racial and ethnic groups in the United States. Am J Cardiol. 2006;97(2a):12a–9a.
Balfour PC Jr, et al. Cardiovascular disease in Hispanics/Latinos in the United States. J Lat Psychol. 2016;4(2):98–113.
Rosamond WD, et al. Twenty-two-year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987–2008. Circulation. 2012;125(15):1848–57.
Al Rifai M, et al. Discordance between 10-year cardiovascular risk estimates using the ACC/AHA 2013 estimator and coronary artery calcium in individuals from 5 racial/ethnic groups: comparing MASALA and MESA. Atherosclerosis. 2018;279:122–9.
Hernandez R, et al. Optimism and cardiovascular health: multi-ethnic study of atherosclerosis (MESA). Health Behav Policy Rev. 2015;2(1):62–73.
Orimoloye OA, et al. Association between self-rated health, coronary artery calcium scores, and atherosclerotic cardiovascular disease risk: the multi-ethnic study of atherosclerosis (MESA). JAMA Netw Open. 2019;2(2):e188023.
Arias E, Xu J, Kochanek KD. United States life tables, 2016. Natl Vital Stat Rep. 2019;68(4):1–66.
Curtin SC, Arias E. Mortality trends by race and ethnicity among adults aged 25 and over: United States, 2000–2017. NCHS Data Brief. 2019(342):1–8.
Yancy CW, et al. The coalition to reduce racial and ethnic disparities in cardiovascular disease outcomes (credo): why credo matters to cardiologists. J Am Coll Cardiol. 2011;57(3):245–52.
Woolf SH, Schoomaker H. Life expectancy and mortality rates in the United States, 1959–2017. JAMA. 2019;322(20):1996–2016.
Kim EJ, et al. Racial/ethnic disparities among Asian Americans in inpatient acute myocardial infarction mortality in the United States. BMC Health Serv Res. 2018;18(1):370.
Loehr LR, et al. Heart failure incidence and survival (from the atherosclerosis risk in communities study). Am J Cardiol. 2008;101(7):1016–22.
Oyenuga AO, et al. Greater adherence to life’s simple 7 is associated with less arterial stiffness: the atherosclerosis risk in communities (ARIC) study. Am J Hypertens. 2019;32(8):769–76.
Kesireddy V, et al. The Association of Life’s Simple 7 with aldosterone among African Americans in the Jackson Heart Study. Nutrients. 2019;11(5):955.
Oyenuga AO, et al. Association of Life’s Simple 7 with reduced clinically manifest abdominal aortic aneurysm: the ARIC study. Vasc Med. 2019;24(3):224–9.
Kershaw KN, et al. Neighborhood-level racial/ethnic residential segregation and incident cardiovascular disease: the multi-ethnic study of atherosclerosis. Circulation. 2015;131(2):141–8.
Taylor AL, et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004;351(20):2049–57.
Yancy CW, et al. 2017 ACC/AHA/HFSA Focused update of the 2013 ACCF/AHA Guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail. 2017;23(8):628–51.
Esenwa C, et al. Racial differences in mechanical thrombectomy utilization for ischemic stroke in the United States. Ethn Dis. 2020;30(1):91–6.
McGrath RP, et al. The burden of health conditions across race and ethnicity for aging Americans: disability-adjusted life years. Medicine (Baltimore). 2019;98(46):e17964.
Shen AY, et al. Racial/ethnic differences in the prevalence of atrial fibrillation among older adults--a cross-sectional study. J Natl Med Assoc. 2010;102(10):906–13.
Sanchez JM, et al. Incident atrial fibrillation among American Indians in California. Circulation. 2019;140(19):1605–6.
Carnethon MR, Kershaw KN, Kandula NR. Disparities research, disparities researchers, and health equity. JAMA. 2019; https://doi.org/10.1001/jama.2019.19329. [Epub ahead of print].
Magnani JW, et al. Racial differences in atrial fibrillation-related cardiovascular disease and mortality: the atherosclerosis risk in communities (ARIC) study. JAMA Cardiol. 2016;1(4):433–41.
Volgman AS, et al. Sex and race/ethnicity differences in atrial fibrillation. J Am Coll Cardiol. 2019;74(22):2812–5.
Dummer PD, et al. APOL1 Kidney disease risk variants: an evolving landscape. Semin Nephrol. 2015;35(3):222–36.
Steffen BT, et al. Race-based differences in lipoprotein(a)-associated risk of carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 2019;39(3):523–9.
Guan W, et al. Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35(4):996–1001.
Ruberg FL, et al. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(22):2872–91.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ferdinand, K.C., Ali, A., Echols, M.R. (2021). Racial/Ethnic Considerations in the Prevention of Cardiovascular Disease. In: Wong, N.D., Amsterdam, E.A., Toth, P.P. (eds) ASPC Manual of Preventive Cardiology. Contemporary Cardiology. Springer, Cham. https://doi.org/10.1007/978-3-030-56279-3_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-56279-3_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-56278-6
Online ISBN: 978-3-030-56279-3
eBook Packages: MedicineMedicine (R0)